Vue transversale globale

Toutes les maladies

Un même point d’entrée pour les études cliniques, les découvertes scientifiques, les publications et les pistes exploratoires présentes dans Biomedical Watch.

Périmètre

Filtrer toute la vue

Chaque choix s’applique immédiatement aux quatre sections. Le filtre « type de SEP » n’apparaît que lorsque la sclérose en plaques est sélectionnée.

Tout réinitialiser Actualisation…
Essais et traitements6003Données cliniques et programmes
Recherches et trouvailles21Pipeline scientifique
Publications4910Références reliées aux maladies
Pistes exploratoires0Hypothèses non validées
10934 résultats correspondants · 41 visibles sur cette page dans le périmètre Toutes les maladies
Niveau clinique

Études et traitements 6003

Interventions, programmes et essais cliniques rattachés au périmètre sélectionné.

Molécule / élément Maladie / population Objectif Phase / stade Statut / preuve Mécanisme / résumé Source Détail
Vagus nerve stimulation NCT06237595 · Vagus Nerve Stimulation in Fibromyalgia Myopathies À vérifier Non applicable COMPLETED Vagus nerve stimulation is thought to reduce sympathetic nerve outflow and… À vérifier ClinicalTrials.gov 2026-08-13 14:28:34 Détail
Development of a Therapeutic Endpoint in Pediatric Rheumatologic Cond… NCT04833465 · NCT04833465 Lupus Traitement symptomatique À vérifier RECRUITING The overarching goal of this study is the development of a physiologic end… À vérifier ClinicalTrials.gov 2026-08-13 14:28:33 Détail
Ianalumab NCT05624749 · Phase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patien… Lupus À vérifier Phase 3 ACTIVE_NOT_RECRUITING The purpose of this study is to evaluate long-term safety and tolerability… À vérifier ClinicalTrials.gov 2026-08-13 14:28:33 Détail
Ianalumab NCT05639114 · Phase 3 Study to Evaluate Two Regimens of Ianalumab on Top of Standard-of-care T… Lupus À vérifier Phase 3 ACTIVE_NOT_RECRUITING The purpose of this study is to evaluate long-term safety and tolerability… À vérifier ClinicalTrials.gov 2026-08-13 14:28:32 Détail
LMY-922 NCT07729995 · BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Autoimmune Disease Lupus Immunomodulation · Thérapie cellulaire Phase 1 NOT_YET_RECRUITING Therapy with chimeric antigen receptor T (CAR-T) cells has demonstrated ac… À vérifier ClinicalTrials.gov 2026-08-13 14:28:32 Détail
Medi-546 NCT04877691 · Tulip SC — Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythe… Lupus À vérifier Phase 3 ACTIVE_NOT_RECRUITING The purpose of this study is evaluating the efficacy and safety of SC anti… À vérifier ClinicalTrials.gov 2026-08-13 14:28:32 Détail
Cenerimod NCT07201129 · LUMIOS — A Research Trial to Assess if Cenerimod is Efficacious and Safe to Trea… Lupus Thérapie génique Phase 3 RECRUITING The goal of this clinical trial is to learn if cenerimod, on top of regula… À vérifier ClinicalTrials.gov 2026-08-13 14:28:31 Détail
Cenerimod 0.5 mg NCT03742037 · Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subj… Lupus À vérifier Phase 2 COMPLETED The purpose of the study is to assess the efficacy and safety of 4 doses o… À vérifier ClinicalTrials.gov 2026-08-13 14:28:31 Détail
Cenerimod 4 mg NCT07266090 · A Study to Evaluate the Safety,Tolerability,Pharmacokinetics and Pharmacodynamic… Lupus À vérifier Phase 2 ACTIVE_NOT_RECRUITING The purpose of the study is to assess the efficacy and safety of 4 doses o… À vérifier ClinicalTrials.gov 2026-08-13 14:28:31 Détail
SLEIGH — Systemic Lupus Erythematosus in Gullah Health NCT00756769 · NCT00756769 Lupus Ralentissement de la progression · Traitement symptomatique À vérifier RECRUITING Systemic lupus erythematosus (SLE) is an autoimmune disease characterized… À vérifier ClinicalTrials.gov 2026-08-13 14:28:31 Détail
Surovatamig NCT07201558 · ASSURO — Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA… Lupus À vérifier Phase 1 RECRUITING This open-label, Phase I study will assess the safety and tolerability of… À vérifier ClinicalTrials.gov 2026-08-13 14:28:31 Détail
Afimetoran NCT04895696 · A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo i… Lupus À vérifier Phase 2 ACTIVE_NOT_RECRUITING The purpose of this study is to evaluate the effectiveness, safety and tol… À vérifier ClinicalTrials.gov 2026-08-13 14:28:30 Détail
Anifrolumab NCT05138133 · IRIS — Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative… Lupus À vérifier Phase 3 ACTIVE_NOT_RECRUITING This is an observational study, in which the main research question is to… À vérifier ClinicalTrials.gov 2026-08-13 14:28:30 Détail
Anti-CD19 CAR PBL NCT00068003 · Harvesting Cells for Experimental Cancer Treatments Cancer À vérifier À vérifier ENROLLING_BY_INVITATION Background: The NCI Surgery Branch has developed experimental therapies th… À vérifier ClinicalTrials.gov 2026-08-13 14:28:26 Détail
A Self-management Based Survivorship Intervention for Chinese Cancer… NCT05534386 · NCT05534386 Cancer Traitement symptomatique Non applicable RECRUITING This study, using a sequential multiple assessment randomized controlled t… À vérifier ClinicalTrials.gov 2026-08-13 14:28:26 Détail
Estrogen NCT05562518 · GRACE-trial: a Randomized Active-controlled Trial for vulvovaGinal atRophy in br… Cancer À vérifier Phase 4 COMPLETED In this prospective active-controlled randomized trial the investigators w… À vérifier ClinicalTrials.gov 2026-08-13 14:28:26 Détail
Multiple Level Intertransverse Process Block NCT07763756 · Single vs Multiple Injection Intertransverse Process Block in Breast Cancer Surg… Cancer À vérifier Non applicable NOT_YET_RECRUITING This randomized clinical trial aims to evaluate and compare the analgesic… À vérifier ClinicalTrials.gov 2026-08-13 14:28:26 Détail
Prospective Evaluation of High Resolution Dual Energy Computed Tomogr… NCT04431024 · Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imagi… Cancer Thérapie génique À vérifier RECRUITING Background: A germline mutation is a change to a person s genes that is ca… À vérifier ClinicalTrials.gov 2026-08-13 14:28:26 Détail
Real World Asparaginase Therapy Toxicity NCT07008027 · NCT07008027 Cancer Thérapie génique À vérifier NOT_YET_RECRUITING This research study is being done to learn more about the short term and l… À vérifier ClinicalTrials.gov 2026-08-13 14:28:26 Détail
Venetoclax NCT07762508 · A Prospective Single-Arm Study of VABu Conditioning Regimen in Allo-HSCT for Low… Cancer Thérapie cellulaire · Thérapie génique Non applicable NOT_YET_RECRUITING This study evaluates the effectiveness and safety of a new conditioning re… À vérifier ClinicalTrials.gov 2026-08-13 14:28:26 Détail
Découverte scientifique

Recherches et trouvailles 21

Projets précliniques, publications émergentes et programmes de recherche suivis dans le pipeline.

Molécule / élément Maladie / population Objectif Phase / stade Statut / preuve Mécanisme / résumé Source Détail
4-octyl itaconate et dérivés Dérivés de l’itaconate — neuroinflammation Sclérose latérale amyotrophique Neuroprotection · Immunomodulation Découverte fondamentale Exploratoire Modulation immunométabolique de la microglie · NRF2 / inflammation microgl… Piste mécanistique visant à reprogrammer la réponse inflammatoire de la microglie. Le lien avec la SLA reste exploratoi… Revue scientifique 2024-07-01 Détail
Bibliographie

Publications 4910

Références bibliographiques de la base locale et accès à leur source originale.

Molécule / élément Maladie / population Objectif Phase / stade Statut / preuve Mécanisme / résumé Source Détail
A comparative study of the role of crocin and sitagliptin in attenuat… Standard Oral Hypoglycemic Agent · PMID 31394428 Maladie rénale chronique Ralentissement de la progression · Immunomodulation Publication PubMed Voir la publication source Type 1 diabetes mellitus (T1DM) describes a complex group of metabolic disorders associated with elevated blood glucose… Environmental toxicology and pharmacology 2026-11-15 04:38:02 Source
Anti diabetic effect of Achyranthes rubrofusca leaf extracts on allox… Standard Oral Hypoglycemic Agent · PMID 21454169 Maladie rénale chronique À vérifier Publication PubMed Voir la publication source The aqueous and ethanolic extracts of Achyranthes rubrofuca leaves (AR) were studied for their hypoglycemic activity. T… Pakistan journal of pharmaceutical sciences 2026-11-15 04:38:02 Source
Antihyperglycemic and hypolipidemic activities of Setaria italica see… Standard Oral Hypoglycemic Agent · PMID 20869855 Maladie rénale chronique À vérifier Publication PubMed Voir la publication source Setaria italica is commonly known as Foxtail millet. In India it is chiefly cultivated in Andhra Pradesh and Tamilnadu.… Pathophysiology : the official journal of the Internat… 2026-11-15 04:38:02 Source
Enhancing neoadjuvant immunotherapy for locally advanced rectal cance… HJB647 high dose · PMID 42860120 Cancer Immunomodulation Publication PubMed Voir la publication source Conventional surgery for locally advanced rectal cancer (LARC) faces challenges including difficult sphincter preservat… Biomaterials 2026-11-15 04:37:50 Source
Oxygen-vacancy-rich LDH sonosensitizers potentiate narrow-spectrum an… HJB647 high dose · PMID 42910182 Insuffisance cardiaque Neuroprotection · Immunomodulation · Thérapie génique Publication PubMed Voir la publication source Mixed bacterial infections, including Gram-positive and Gram-negative pathogens, remain a major global health concern.… Bioactive materials 2026-11-15 04:37:50 Source
Respiratory Support With Nasal High Flow Reduces Opioid Requirements… HJB647 high dose · PMID 42699223 Insuffisance cardiaque À vérifier Publication PubMed Voir la publication source Nasal high flow (NHF) improves oxygenation, reduces the work of breathing, and stabilizes ventilation. In endoscopic re… DEN open 2026-11-15 04:37:50 Source
Feasibility of a Deep-Learning Model for Objective Visualization-Qual… Lithotripsy · PMID 42898633 Maladie coronarienne À vérifier Publication PubMed Voir la publication source During peroral cholangioscopy-guided electrohydraulic lithotripsy (EHL), stone fragmentation obscures the visual field… DEN open 2026-11-15 04:37:45 Source
Impact of calcium burden, lesion preparation, and lithotripsy on sten… Lithotripsy · PMID 42777787 Maladie coronarienne À vérifier Publication PubMed Voir la publication source Stent underexpansion in severely calcified coronary lesions increases the risk of target vessel failure. Intravascular… International journal of cardiology 2026-11-15 04:37:45 Source
Intravascular lithotripsy for calcific stenosis of the abdominal aort… Lithotripsy · PMID 43001236 Maladie coronarienne À vérifier Publication PubMed Voir la publication source Takayasu arteritis is a rare large-vessel vasculitis that predominantly affects the aorta and its major branches. Altho… Journal of vascular surgery cases and innovative techn… 2026-11-15 04:37:45 Source
Placenta-derived mesenchymal stem cells for prenatal myelomeningocele… cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cells · PMID 42… Sclérose en plaques · Sclérose latérale amyotrophique · Sclérose laté… Thérapie cellulaire Publication PubMed Voir la publication source Résumé non disponible dans la base locale. Annals of translational medicine 2026-11-15 04:37:41 Source
Synovial Biomarker Modulation and Clinical Response to Umbilical Cord… cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cells · PMID 42… Sclérose en plaques · Sclérose latérale amyotrophique · Sclérose laté… Immunomodulation · Thérapie cellulaire Publication PubMed Voir la publication source ObjectiveUmbilical cord-derived mesenchymal stromal cells (UC-MSCs) are a promising treatment for knee osteoarthritis (… Cartilage 2026-11-15 04:37:41 Source
Design, synthesis, and biological evaluation of 1H-1,2,4-triazole-3-c… B007 · PMID 42142713 Insuffisance cardiaque À vérifier Publication PubMed Voir la publication source The apelin receptor (AplnR) is a prominent peptide-binding Class A G protein-coupled receptor (GPCR) involved in the re… Bioorganic & medicinal chemistry letters 2026-11-15 04:37:34 Source
Programmable Nanobody-Targeting Chimeras Enable Intracellular Viral P… B007 · PMID 42467897 Myasthénie À vérifier Publication PubMed Voir la publication source Chronic hepatitis B virus (HBV) infection remains a major global health challenge, largely because current antiviral th… Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2026-11-15 04:37:34 Source
Understanding the Selectivity of Selective Oxidation of Propane to Ac… B007 · PMID 41768713 Myasthénie À vérifier Publication PubMed Voir la publication source In this work, we have performed a quantum chemical investigation for the selective oxidation of propane toward acrylic… ACS omega 2026-11-15 04:37:34 Source
Comparative efficacy and acceptability of antidepressants in the long… Milnacipran · PMID 43008763 Myopathies À vérifier Publication PubMed Voir la publication source Major depressive disorder carries high risks of relapse and chronicity, necessitating treatments that achieve and maint… The lancet. Psychiatry 2026-11-15 04:37:30 Source
Polysubstance-Induced Vasoplegia Managed with Venoarterial Extracorpo… Milnacipran · PMID 43014364 Myopathies À vérifier Publication PubMed Voir la publication source While the use of venoarterial extracorporeal membrane oxygenation (VA-ECMO) becomes increasingly commonplace in overdos… Clinical practice and cases in emergency medicine 2026-11-15 04:37:30 Source
Early Outcome of a Single Peri-Tendinous Hyaluronic Acid Injection fo… Sodium hyaluronate with mannitol (Ostenil Tendon) · PMID 33132010 Myopathies Traitement symptomatique Publication PubMed Voir la publication source The aim of this study was to evaluate the efficacy and safety of a single, peri-tendinous injection of hyaluronic acid… Foot (Edinburgh, Scotland) 2026-11-15 04:37:29 Source
Engineered stem cell-derived CD16-enhanced universal NKT cells improv… Tafasitamab and NK cells · PMID 43008138 Cancer Immunomodulation · Thérapie cellulaire Publication PubMed Voir la publication source Monoclonal antibody (mAb)-based therapies have revolutionized cancer treatment; however, their clinical efficacy is oft… Cancer immunology research 2026-11-15 04:37:24 Source
Precision Fc remodeling via glycosylation-competent CHO display enabl… Tafasitamab and NK cells · PMID 41923108 Cancer Immunomodulation Publication PubMed Voir la publication source BACKGROUND: Improving tumor cell clearance by therapeutic antibodies remains a translational bottleneck because wild-ty… Journal of biological engineering 2026-11-15 04:37:24 Source
The Fc-engineered CD19 antibody MOR208 (XmAb5574) induces natural kil… Tafasitamab and NK cells · PMID 23277329 Lupus À vérifier Publication PubMed Voir la publication source Résumé non disponible dans la base locale. Leukemia 2026-11-15 04:37:24 Source
Exploration — prudence

Pistes exploratoires 0

Rapprochements mécanistiques et hypothèses de recherche : ils ne constituent pas une preuve d’efficacité ni une recommandation thérapeutique.

Hypothèses non validéesÀ confirmer par des travaux précliniques, cliniques et une revue scientifique indépendante.
Molécule / élément Maladie / population Objectif Phase / stade Statut / preuve Mécanisme / résumé Source Détail
Aucune piste exploratoire ne correspond aux filtres.